ClinicalTrials.Veeva
Menu

Find clinical trials for Multiple Myeloma in Jacksonville, FL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Plasma Cell Cancer
Hematologic Cancer
Lymphoma
Cancer
Leukemia
Smoldering Multiple Myeloma
Non-Hodgkin Lymphoma

Multiple Myeloma trials near Jacksonville, FL, USA:

A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients

This is a phase 1, multicenter, open-label study evaluating the safety and efficacy of ruxolitinib, steroids and lenalidomide among MM patients who c...

Enrolling
Multiple Myeloma
Drug: Ruxolitinib Oral Tablet [Jakafi]
Drug: Methylprednisolone

Phase 1

Oncotherapeutics

Jacksonville, Florida, United States and 12 other locations

versus standard regimens in subjects with relapsed and refractory multiple myeloma (RRMM).The study is anticipated to randomize app...

Active, not recruiting
Multiple Myeloma
Biological: bb2121
Drug: Dexamethasone

Phase 3

Celgene
Celgene

Jacksonville, Florida, United States and 59 other locations

a phase 1b/2, open-label, multicenter study of GC012F (AZD0120), a CD19/BCMA dual CART-cell therapy, in adult subjects with relapsed/refractory Multiple...

Enrolling
Relapsed/ Refractory Multiple Myeloma
Biological: GC012F (AZD0120)

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Jacksonville, Florida, United States and 12 other locations

The purpose of this study is to evaluate the effectiveness and safety of BMS-986393 in participants with relapsed or refractory multiple myeloma...

Enrolling
Multiple Myeloma
Biological: BMS-986393

Phase 2

Juno Therapeutics

Jacksonville, Florida, United States and 46 other locations

(LD-Dex) (Cohort B) in subjects with relapsed or refractory multiple myeloma who have received a first or second line treatment of ...

Active, not recruiting
Multiple Myeloma
Drug: Dexamethasone
Drug: Daratumumab

Phase 2

Celgene
Celgene

Jacksonville, Florida, United States and 48 other locations

with Relapsed/Refractory (r/r) Non-Hodgkin's Lymphoma (NHL) or Multiple Myeloma (MM). Cemsidomide may be administered as a single a...

Enrolling
Multiple Myeloma
Lymphoma, Non-Hodgkin's
Drug: Dexamethasone Oral
Drug: cemsidomide

Phase 1, Phase 2

C4 Therapeutics

Jacksonville, Florida, United States and 12 other locations

antibody (mAb). Renal impairment is a major complication of multiple myeloma (MM) and the majority of MM participants is either at ...

Enrolling
Multiple Myeloma
Drug: Belantamab mafodotin

Phase 1

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Jacksonville, Florida, United States and 25 other locations

Locations recently updated

and tolerable dose of BMS-986393 in combinations with alnuctamab, mezigdomide, and iberdomide in participants with relapsed and/or refractory multiple...

Enrolling
Multiple Myeloma
Drug: Alnuctamab
Drug: Iberdomide

Phase 1

Juno Therapeutics

Jacksonville, Florida, United States and 18 other locations

This is a global, open-label, multi-arm, multi-cohort, multi-center, phase 1/2 study to determine the safety, tolerability, efficacy, PK of bb2121 in...

Active, not recruiting
Multiple Myeloma
Drug: BMS-986405
Biological: BB2121

Phase 1, Phase 2

Celgene
Celgene

Jacksonville, Florida, United States and 16 other locations

Multiple myeloma (MM) is a cancer of the blood's plasma cells. The cancer is typically found in the bones and bone marrow (the spon...

Enrolling
Multiple Myeloma
Drug: Carfilzomib
Drug: Bortezomib

Phase 3

AbbVie
AbbVie

Jacksonville, Florida, United States and 82 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems